Top > Pipeline
 |
Project Name | Type of Compound Main Indications |
R&D Stage |
 |
 YSPSL |
Recombinant P-selectin glycoprotein ligand-1 Ig (rPSGL-Ig) Selectin antagonist Delayed Graft Function in Kidney Transplant, others |
Phase II |
 |
YSCMA |
Anti-CD26 Humanized Monoclonal Antibody Hematological Malignancies, Solid Tumors |
IND |
 |
YSIL6 |
IL-6 Inhibitors Rheumatoid Arthritis |
Lead Selection |
Top | Site Map | Access Map | Privacy Policy | Terms of Use |
